Help:PathwayStyling
From WikiPathways
(Difference between revisions)
(added PDGFR-beta pathway) |
(→PDGFR-beta and ovarian cancer survival) |
||
| Line 13: | Line 13: | ||
{{#imgLink:WP3972_92088.png|thumb|center |WikiPathways model|pathway|WP3972|WikiPathways model}} | {{#imgLink:WP3972_92088.png|thumb|center |WikiPathways model|pathway|WP3972|WikiPathways model}} | ||
|- | |- | ||
| - | |[[Image: | + | |[[Image:PDGFR-beta_original.png|thumb|Original figure]] |
|} | |} | ||
|} | |} | ||
---- | ---- | ||
| + | |||
=== NAD⁺ in aging, metabolism, and neurodegeneration === | === NAD⁺ in aging, metabolism, and neurodegeneration === | ||
(Verdin, ''Science'' 2015) [http://www.ncbi.nlm.nih.gov/pubmed/26785480 PubMed] | (Verdin, ''Science'' 2015) [http://www.ncbi.nlm.nih.gov/pubmed/26785480 PubMed] | ||
Revision as of 18:30, 25 April 2017
Contents |
Styling WikiPathways Models in Cytoscape
A showcase of WikiPathways models styled in Cytoscape to produce high-quality images comparable to original static figures. You can model and then style any biological process, starting from a published figure or your own research results.
PDGFR-beta and ovarian cancer survival
(Zhang, Cell 2016) PubMed
|
|
NAD⁺ in aging, metabolism, and neurodegeneration
(Verdin, Science 2015) PubMed
|
|
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
(Yang, Mol Syst Biol 2014) PubMed
|
|
(Zhang et al, "Cell" 2013) PubMed
|
|
(Fraser et al, "Mol. Cell." 2013) PubMed
|
|
